Efficacy of SASI Bypass in Super Obese Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-01

Study Completion Date

2019-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although previous studies investigated weight loss and improvement in comorbidities after SASI bypass, patients included in these studies had a BMI less than 50 Kg/m2. Therefore, the aim of the present study was to investigate the outcome of SASI bypass in patients with super obesity to assess the success of this novel bariatric procedure in this challenging group of patients in regards weight loss and improvement in associated comorbid conditions at 12 months postoperatively.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Midterm Follow up Outcomes of (SASJ) in Management of Morbid Obesity

NCT07087535

Morbid Obesity Requiring Bariatric Surgery

ACTIVE_NOT_RECRUITING

Bariatric Surgery for Obesity

NCT06901440

Obesity and Obesity-related Medical Conditions Bariatric Surgery Patients

NOT_YET_RECRUITING

SAS-J Compared to OAGB and LSG as a Treatment for Morbid Obesity

NCT03821688

Morbid Obesity

COMPLETED NA

Durability of Weight Loss After Bariatric Surgery

NCT04650373

Obesity

COMPLETED

Outcomes of Sleeve Gastrectomy in Obese Patients, Retrospective Study.

NCT04967053

Morbid Obesity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morbid Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SASI bypass

Patients with super obesity underwent SASI bypass

Group Type EXPERIMENTAL

SASI bypass

Intervention Type PROCEDURE

Sleeve gastrectomy with single loop anastomosis between gastric antrum and ileum, 3 meters away from ileocecal junction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SASI bypass

Sleeve gastrectomy with single loop anastomosis between gastric antrum and ileum, 3 meters away from ileocecal junction

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients included to the present study were adult patients of both genders aging between 18 and 65 years with primary morbid obesity with BMI ≥50 kg/m2 with or without obesity-associated comorbidities such as hypertension, diabetes mellitus (DM), dyslipidemias, and gastroesophageal reflux disease (GERD).

Exclusion Criteria

* Pregnant women.
* Patients unfit for general anasthesia (ASA 4, 5)
* Endocrine or psychiatric disorders.
* History of previous upper abdmominal laparotomy.
* Alcoholic addiction
* Liver cirrhosis
* Coagulopathy

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No